These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27161124)

  • 1. A new measure of between-studies heterogeneity in meta-analysis.
    Crippa A; Khudyakov P; Wang M; Orsini N; Spiegelman D
    Stat Med; 2016 Sep; 35(21):3661-75. PubMed ID: 27161124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of various estimates of the
    Wang Y; DelRocco N; Lin L
    Stat Methods Med Res; 2024 May; 33(5):745-764. PubMed ID: 38502022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-binomial model for meta-analysis of odds ratios.
    Bakbergenuly I; Kulinskaya E
    Stat Med; 2017 May; 36(11):1715-1734. PubMed ID: 28124446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity estimates in a biased world.
    Hönekopp J; Linden AH
    PLoS One; 2022; 17(2):e0262809. PubMed ID: 35113897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of analysing continuous outcomes using final values, change scores and analysis of covariance on the performance of meta-analytic methods: a simulation study.
    McKenzie JE; Herbison GP; Deeks JJ
    Res Synth Methods; 2016 Dec; 7(4):371-386. PubMed ID: 26715122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Confidence intervals for the between-study variance in random-effects meta-analysis using generalised heterogeneity statistics: should we use unequal tails?
    Jackson D; Bowden J
    BMC Med Res Methodol; 2016 Sep; 16(1):118. PubMed ID: 27604952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of heterogeneity variance based on a generalized Q statistic in meta-analysis of log-odds-ratio.
    Kulinskaya E; Hoaglin DC
    Res Synth Methods; 2023 Sep; 14(5):671-688. PubMed ID: 37381621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.
    Bowden J; Tierney JF; Copas AJ; Burdett S
    BMC Med Res Methodol; 2011 Apr; 11():41. PubMed ID: 21473747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis prediction intervals are under reported in sport and exercise medicine.
    Borg DN; Impellizzeri FM; Borg SJ; Hutchins KP; Stewart IB; Jones T; Baguley BJ; Orssatto LBR; Bach AJE; Osborne JO; McMaster BS; Buhmann RL; Bon JJ; Barnett AG
    Scand J Med Sci Sports; 2024 Mar; 34(3):e14603. PubMed ID: 38501202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Between-study Heterogeneity Measures in the Cochrane Library.
    Ma X; Lin L; Qu Z; Zhu M; Chu H
    Epidemiology; 2018 Nov; 29(6):821-824. PubMed ID: 29847495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses.
    Jackson D; White IR; Riley RD
    Stat Med; 2012 Dec; 31(29):3805-20. PubMed ID: 22763950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical Methods for Quantifying Between-study Heterogeneity in Meta-analysis with Focus on Rare Binary Events.
    Zhang C; Chen M; Wang X
    Stat Interface; 2020; 13(4):449-464. PubMed ID: 33628357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential change detection and monitoring of temporal trends in random-effects meta-analysis.
    Dogo SH; Clark A; Kulinskaya E
    Res Synth Methods; 2017 Jun; 8(2):220-235. PubMed ID: 27933728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-Analysis of Rare Binary Adverse Event Data.
    Bhaumik DK; Amatya A; Normand SL; Greenhouse J; Kaizar E; Neelon B; Gibbons RD
    J Am Stat Assoc; 2012 Jun; 107(498):555-567. PubMed ID: 23734068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of safety for low event-rate binomial trials.
    Shuster JJ; Guo JD; Skyler JS
    Res Synth Methods; 2012 Mar; 3(1):30-50. PubMed ID: 24339834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of heterogeneity in meta-analysis.
    Lillo-Albert G; Boscà I Robledo A; Pous-Serrano S
    Cir Esp (Engl Ed); 2024 Apr; ():. PubMed ID: 38697352
    [No Abstract]   [Full Text] [Related]  

  • 17. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
    Zhang Y; Du H; Wang N; Wang L; Huang Y
    BMC Cancer; 2024 Jan; 24(1):129. PubMed ID: 38267901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis.
    Qin H; Liu F; Zhang Y; Liang Y; Mi Y; Yu F; Xu H; Li K; Lin C; Li L; Tian Z; Wang L
    Front Immunol; 2023; 14():1108213. PubMed ID: 37033991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability Generalization Meta-Analysis of Internet Gaming Disorder Scale.
    Gisbert-Pérez J; Martí-Vilar M; Merino-Soto C; Vallejos-Flores M
    Healthcare (Basel); 2022 Oct; 10(10):. PubMed ID: 36292440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative Erythemal Ultraviolet Radiation and Risk of Cancer in 3 Large US Prospective Cohorts.
    Chang MS; Hartman RI; Trepanowski N; Giovannucci EL; Nan H; Li X
    Am J Epidemiol; 2022 Sep; 191(10):1742-1752. PubMed ID: 35671977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.